CHMP Grants Authorisation for GSK's Groundbreaking CKD Drug
London, 26 June 2023: Leading global pharmaceutical company GSK plc has made an announcement stating that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has provided a favourable opinion recommending the authorization of daprodustat. The recommendation is specifically for the treatment of symptomatic anaemia linked to